Skip to main content

Microvast Holdings Inc

For the period ended Mar 31, 2025. Filed May 12, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 12, 2025

MVST$0.22-64.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Unaudited Condensed Consolidated Balance Sheets

March 31,2025December 31,2024
Assets
Current assets:
Cash and cash equivalents$90,898$73,007
Restricted cash, current32,09636,572
Accounts receivable (net of allowance for credit losses of $6,523 and $5,090 as of March 31, 2025 and December 31, 2024, respectively)135,654120,626
Notes receivable10,3627,579
Inventories, net129,059143,327
Prepaid expenses and other current assets30,02727,019
Assets held for sale19,89619,896
Total Current Assets447,992428,026
Restricted cash, non-current—22
Property, plant and equipment, net485,157478,189
Land use rights, net11,36611,371
Acquired intangible assets, net2,4962,607
Operating lease right-of-use assets18,20517,628
Other non-current assets17,71614,024
Total Assets$982,932$951,867
Liabilities
Current liabilities:
Accounts payable$56,771$64,940
Notes payable47,90151,756
Accrued expenses and other current liabilities104,13698,456
Advance from customers44,20443,678
Amounts due to related parties—5
Short-term bank borrowings86,24170,666
Income tax payables653652
Total Current Liabilities339,906330,153
Long-term bonds payable41,69343,157
Long-term bank borrowings41,30241,062
Warrant liability64290
Share-based compensation liability9898
Operating lease liabilities14,79314,596
Convertible loan measured at fair value60,996104,613
Other non-current liabilities29,84530,003
Total Liabilities$528,697$563,972

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - continued

March 31,2025December 31,2024
Commitments and contingencies (Note 16)
Stockholders’ Equity
Common Stock (par value of US$0.0001 per share, 750,000,000 and 750,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 325,216,389 and 324,831,634 shares issued, and 323,528,889 and 323,144,134 shares outstanding as of March 31, 2025 and December 31, 2024)$33$33
Additional paid-in capital1,513,6851,512,982
Statutory reserves6,0326,032
Accumulated deficit(1,031,168)(1,092,958)
Accumulated other comprehensive loss(34,347)(38,194)
Total Equity$454,235$387,895
Total Liabilities and Equity$982,932$951,867
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.